azomycin has been researched along with Rhabdomyosarcoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bol, A; Bol, V; Gallez, B; Grégoire, V; Jordan, B; Karroum, O; Labar, D; Tran, LB | 1 |
| Dubois, L; Eriksson, J; Lambin, P; Lieuwes, NG; Peeters, SG; van Dongen, GA; van Elmpt, W; Zegers, CM | 1 |
| Bol, A; Cao-Pham, TT; Gallez, B; Grégoire, V; Jordan, B; Labar, D; Tran, LB | 1 |
| Baruchel, S; Kumar, S; Marrano, P; Thorner, P; Wu, B; Zhang, L | 1 |
| Bol, A; Bormans, G; Cloetens, L; Dubois, L; Grégoire, V; Haustermans, K; Labar, D; Landuyt, W; Mortelmans, L; Nuyts, J | 1 |
| Bol, A; Gallez, B; Grégoire, V; Jordan, B; Labar, D; Magat, J; Mignion, L; Tran, LB | 1 |
| Bormans, G; Dubois, L; Dupont, P; Flamen, P; Haustermans, K; Landuyt, W; Mortelmans, L; Verbeken, E; Vermaelen, P | 1 |
| Afzal, SM; Curtis, SB; Tenforde, TS | 1 |
| Crabtree, KE; Curtis, SB; Flynn, MJ; Howard, J; Lyman, JT; Parr, SS; Tenforde, SD; Tenforde, TS | 1 |
| Afzal, SM; Curtis, SB; Howard, J; Lyman, JT; Parr, SS; Tenforde, TS | 1 |
| Salwińska, E; Suwiński, J; Watras, J; Widel, M | 1 |
| Benard, P; Canal, P; Laurent, F; Soula, G | 1 |
| Salwińska, E; Suwiński, J; Watras, J; Wideł, M | 1 |
13 other study(ies) available for azomycin and Rhabdomyosarcoma
| Article | Year |
|---|---|
Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy.
Topics: Animals; Carbon Dioxide; Cell Hypoxia; Diagnostic Imaging; Disease Models, Animal; Glioma; Male; Nitroimidazoles; Oximetry; Oxygen; Partial Pressure; Positron-Emission Tomography; Prognosis; Radiotherapy Planning, Computer-Assisted; Random Allocation; Rats; Rats, Inbred F344; Rhabdomyosarcoma | 2014 |
A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Computer Simulation; Imidazoles; Misonidazole; Models, Biological; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Triazoles | 2015 |
Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study.
Topics: Animals; Cell Hypoxia; Chemoradiotherapy; Disease Models, Animal; Fluorine Radioisotopes; Glioma; Male; Nimorazole; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Rats; Rats, Inbred F344; Rhabdomyosarcoma | 2015 |
Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models.
Topics: Activation, Metabolic; Administration, Metronomic; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Inhibitory Concentration 50; Mice, Inbred NOD; Mice, SCID; Neuroblastoma; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Rhabdomyosarcoma; Topotecan; Xenograft Model Antitumor Assays | 2016 |
[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.
Topics: Animals; Autoradiography; Biomarkers; Heart; Hypoxia; Male; Misonidazole; Myocardium; Nitroimidazoles; Positron-Emission Tomography; Rats; Reference Values; Rhabdomyosarcoma; Tissue Distribution | 2009 |
Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry.
Topics: Animals; Cell Hypoxia; Fluorine Radioisotopes; Magnetic Resonance Imaging; Male; Neoplasms, Experimental; Nitroimidazoles; Oximetry; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rhabdomyosarcoma | 2012 |
Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry.
Topics: Animals; Antibodies, Monoclonal; Carbonic Anhydrase III; Cell Hypoxia; Fluorodeoxyglucose F18; Heart; Immunoenzyme Techniques; Lung; Male; Misonidazole; Muscles; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Rats; Rhabdomyosarcoma | 2004 |
Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
Topics: Animals; Carbon; Combined Modality Therapy; Ions; Misonidazole; Neon; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Particle Accelerators; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Rats; Relative Biological Effectiveness; Rhabdomyosarcoma | 1984 |
Misonidazole enhancement of radiation-induced growth delay in rat rhabdomyosarcoma tumours exposed to accelerated carbon and neon ions.
Topics: Animals; Carbon; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Misonidazole; Neon; Nitroimidazoles; Particle Accelerators; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; Sarcoma, Experimental | 1981 |
Increased enhancement of tumour response to X-rays and high-LET neon ions by desmethylmisonidazole relative to misonidazole.
Topics: Animals; Dose-Response Relationship, Radiation; Energy Transfer; Misonidazole; Neon; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; X-Rays | 1982 |
Radiosensitization of the rats' rhabdomyosarcoma R 1 by chloronitroimidazole compound--P40 dependent on radiation dose in fractionated radiotherapy.
Topics: Animals; Combined Modality Therapy; Female; Male; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Rats; Rhabdomyosarcoma | 1990 |
Autoradiographic distribution of [14C]-labelled pimonidazole in rhabdomyosarcoma-bearing rats and pigmented mice.
Topics: Animals; Autoradiography; Male; Mice; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; Tissue Distribution | 1988 |
2-Chloro-4-nitroimidazole radiosensitizers of hypoxic tumor cells in vivo.
Topics: Algorithms; Animals; Hypoxia; Lethal Dose 50; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Rats; Rats, Inbred Strains; Rhabdomyosarcoma | 1987 |